Ruiyan Zhang Selected Research

Interleukin-1 (Interleukin 1)

3/2019	Recombinant human interleukin-1 receptor antagonist treatment protects rats from myocardial ischemia-reperfusion injury.
10/2011	Interleukin-1 signaling mediates acute doxorubicin-induced cardiotoxicity.
9/2010	Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruiyan Zhang Research Topics

Disease

13	Myocardial Infarction 01/2023 - 02/2002
12	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 10/2010
12	Thrombosis (Thrombus) 10/2021 - 12/2011
9	Neoplasms (Cancer) 02/2023 - 09/2010
9	Heart Failure 01/2022 - 09/2010
7	Atherosclerosis 04/2024 - 10/2016
7	Inflammation (Inflammations) 11/2022 - 01/2017
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2015
6	Chronic Renal Insufficiency 04/2024 - 12/2014
6	Reperfusion Injury 03/2019 - 01/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2014
5	ST Elevation Myocardial Infarction 09/2023 - 01/2014
5	Infarction (Infarctions) 01/2021 - 02/2002
4	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 06/2020
4	Hypertension (High Blood Pressure) 10/2021 - 10/2003
3	Neuroinflammatory Diseases 07/2023 - 06/2020
3	Hemorrhage 01/2022 - 03/2019
3	Infections 01/2021 - 01/2016
3	Death (Near-Death Experience) 01/2020 - 12/2014
3	Stroke (Strokes) 01/2020 - 03/2019
3	Cardiotoxicity 06/2015 - 09/2010
2	Pathologic Constriction (Stenosis) 05/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 05/2024 - 10/2010
2	Multiple Sclerosis 07/2023 - 01/2022
2	COVID-19 04/2023 - 12/2020
2	Ventricular Remodeling 01/2023 - 03/2021
2	Osteoarthritis 09/2021 - 01/2015
2	Rupture 01/2021 - 10/2020
2	Diabetes Mellitus 01/2020 - 01/2017
2	Renal Insufficiency (Renal Failure) 11/2019 - 10/2010
2	Hyperplasia 10/2018 - 12/2011
2	Left Ventricular Dysfunction 08/2017 - 02/2016
2	AIDS-Related Complex (ARC) 01/2017 - 01/2014
1	Atherosclerotic Plaque (Atheroma) 05/2024
1	Vascular Calcification 04/2024
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023
1	Post-Acute COVID-19 Syndrome 05/2023
1	Ischemia 02/2023
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2022
1	Cardiomyopathies (Cardiomyopathy) 12/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Fibrosis (Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2015
4	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2014
3	CarbohydratesIBA 05/2023 - 10/2020
3	CuprizoneIBA 01/2022 - 06/2020
3	CollagenIBA 01/2022 - 01/2020
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2019 - 09/2010
3	Interleukin-1 (Interleukin 1)IBA 03/2019 - 09/2010
3	Sulfates (Sulfates, Inorganic)IBA 10/2016 - 12/2014
2	Tyrosine (L-Tyrosine)FDA Link 10/2023 - 01/2022
2	Chemokine ReceptorsIBA 10/2023 - 01/2022
2	LipidsIBA 05/2023 - 01/2016
2	Galectin 3 (LGALS3)IBA 01/2022 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2020
2	Thrombin FDA Link 01/2021 - 10/2010
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 03/2015
2	polysialic acidIBA 01/2021 - 08/2019
2	CreatinineIBA 12/2020 - 10/2010
2	Amyloid (Amyloid Fibrils)IBA 10/2020 - 01/2016
2	Neuroprotective AgentsIBA 10/2020 - 06/2020
2	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 09/2019 - 02/2019
2	Triglycerides (Triacylglycerol)IBA 09/2019 - 01/2017
2	Lipase (Acid Lipase)FDA Link 09/2019 - 02/2019
2	Polysaccharides (Glycans)IBA 08/2019 - 01/2016
2	dectin 1IBA 01/2019 - 01/2019
2	PolymersIBA 03/2017 - 10/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011 - 09/2010
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2024
1	Histones (Histone)IBA 04/2024
1	hydroxide ionIBA 04/2024
1	Orphan Nuclear ReceptorsIBA 04/2024
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 04/2024
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 04/2024
1	tyrosine O-sulfateIBA 10/2023
1	Amino Acids FDA Link 05/2023
1	Sialic AcidsIBA 05/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2023
1	Antiviral Agents (Antivirals)IBA 04/2023
1	COVID-19 VaccinesIBA 04/2023
1	B-Cell Activating FactorIBA 02/2023
1	Dyrk KinasesIBA 02/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	TicagrelorIBA 01/2022
1	trimethyllysineIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	RGFP966IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	plerixafor FDA Link 01/2022

Therapy/Procedure

13	Stents 01/2023 - 12/2011
7	Therapeutics 01/2022 - 02/2002
5	Ketogenic Diet 12/2023 - 06/2020
3	Drug-Eluting Stents 03/2017 - 12/2011
2	Percutaneous Coronary Intervention 09/2023 - 01/2022